AVAH
Aveanna Healthcare·NASDAQ
--
--(--)
--
--(--)
5.50 / 10
Netural
Analyst consensus is split (2 Buy, 2 Neutral) with weak positioning. Fund‑flow rating is good (7.89/10) showing mixed inflows—block and large investors positive, overall trend negative—supporting a cautious stance.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
50%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-25
InstitutionBarclays
Times predicted4
Historical Win Rate25.0%
What is the analyst consensus for AVAH?
- AVAH holds a Bearish analyst rating, with 50% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.50/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
